DavidFranklinFiorentinoMDPhD
Dermatology • Stanford, CAAssociate Professor, Dermatology, Stanford University Medical Center
Dr. Fiorentino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-723-7796
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 1999 - 2002
University of ColoradoInternship, Internal Medicine, 1998 - 1999
Stanford University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2026- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus Start of enrollment: 2006 Aug 01
- A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease Start of enrollment: 2006 Aug 01
- A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Start of enrollment: 2008 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 398 citationsThe mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective studyDavid Fiorentino, Lorinda Chung, Jeff Zwerner, Antony Rosen, Livia Casciola-Rosen
Journal of the American Academy of Dermatology. 2011-07-01 - 485 citationsRapamycin selectively inhibits interleukin-2 activation of p70 S6 kinaseCalvin J. Kuo, Jongkyeong Chung, David Fiorentino, W. Michael Flanagan, John Blenis
Nature. 1992-07-02 - 25 citationsChromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis.Qian Liu, Lisa C. Zaba, Ansuman T. Satpathy, Michelle Longmire, Wen Zhang
Nature Communications. 2020-11-17
Journal Articles
- Clinical Significance of Autoantibodies in Dermatomyositis and Systemic SclerosisDavid F Fiorentino, Lorinda Chung, ScienceDirect
Press Mentions
Autoantibodies Signal Reduced Cancer Risk in DermatomyositisFebruary 17th, 2023- FDA Approves New Drug, Sotyktu, for Treatment of Plaque PsoriasisSeptember 10th, 2022
- Reviewers' List December 2020August 12th, 2020
- Join now to see all
Professional Memberships
- Member
- Fellow
- Clinical Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
